Atossa Therapeutics, Inc.
ATOSNASDAQHealthcare● Active
$4.50
$-0.05(-1.10%)
Market Cap$38751426
P/E Ratio—
52W High$19.35
52W Low$3.76
Atossa Therapeutics, Inc. (ATOS) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · ATOS · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.04B | $0.07B | $0.09B | $0.11B | $0.14B |
| Net Receivables | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Inventory | $0.00B | $0.00B | $0.00B | $0.01B | $0.00B |
| Total Current Assets | $0.05B | $0.07B | $0.09B | $0.12B | $0.14B |
| PP&E Net | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Assets | $0.05B | $0.08B | $0.10B | $0.12B | $0.14B |
| Liabilities | |||||
| Short-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Current Liabilities | $0.01B | $0.00B | $0.01B | $0.01B | $0.00B |
| Long-Term Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Liabilities | $0.01B | $0.00B | $0.01B | $0.01B | $0.00B |
| Stockholders Equity | |||||
| Retained Earnings | ($0.25B) | ($0.21B) | ($0.19B) | ($0.16B) | ($0.13B) |
| Total Stockholders Equity | $0.04B | $0.07B | $0.09B | $0.12B | $0.14B |
| Total Liab & Equity(computed) | $0.05B | $0.08B | $0.10B | $0.12B | $0.14B |
| Debt Summary | |||||
| Total Debt | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Debt | ($0.04B) | ($0.07B) | ($0.09B) | ($0.11B) | ($0.14B) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Atossa Therapeutics, Inc. data
About Atossa Therapeutics, Inc. (ATOS) Balance Sheet
Atossa Therapeutics, Inc. (ATOS) balance sheet shows total assets of $0.05B with cash of $0.04B. Total liabilities are $0.01B, total debt $0.00B, and stockholders equity $0.04B.
Frequently asked questions
ATOS · 4 questionsAtossa Therapeutics, Inc. has total debt of $0.00B with net debt of ($0.04B).
ATOS total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10